Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

277.87
Delayed Data
As of Mar 22
 +2.08 / +0.75%
Today’s Change
205.42
Today|||52-Week Range
307.33
+6.38%
Year-to-Date
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
Dow, S&P 500 Decline as Health Care Losses Counter Gains
Mar 17 / TheStreet.com - Paid Partner Content
Five Stocks I Like on the Nasdaq Market
Mar 21 / GuruFocus News - Paid Partner Content
Stock Market News for March 17, 2017
Mar 17 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
Cramer: Confusion Reigns in This Market
Mar 16 / TheStreet.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Analysts' Actions -- Liberty Global, RPM International, TJX, Biogen and More
Mar 16 / TheStreet.com - Paid Partner Content
European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details
Mar 20 / TheStreet.com - Paid Partner Content
Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise
Mar 13 / Zacks.com - Paid Partner Content
European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade
Mar 20 / TheStreet.com - Paid Partner Content
AbbVie Stock Upgraded: What You Need to Know
Mar 10 / MotleyFool.com - Paid Partner Content
Alkermes Starts Phase III Study to Treat Multiple Sclerosis
Mar 17 / Zacks.com - Paid Partner Content
Why Ionis Pharmaceuticals Rallied 12% in February
Mar 09 / MotleyFool.com - Paid Partner Content
Week in Review: Stocks Post Small Gains After Fed Pulls Trigger on Third Hike Since C...
Mar 17 / TheStreet.com - Paid Partner Content
Trump vows to bring drug prices 'way down'
Mar 07 / CNNMoney.com